Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above
Background: Two kinds of regimens (2-1-1 and 1-1-1-1-1) can be selected after Zagreb regimen(2-1-1)of PVRV was officially approved in Beijing in January 2015. Up to now, the subjects for most studies about the comparison between Zagreb and Essen regimen are under 50 y old, rarely at and above. Aging...
שמור ב:
| Principais autores: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2017-01-01
|
| סדרה: | Human Vaccines & Immunotherapeutics |
| נושאים: | |
| גישה מקוונת: | http://dx.doi.org/10.1080/21645515.2016.1230260 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|